| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
159,210,000 |
| Market
Cap: |
1.03(B) |
| Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,382 |
| 52
Week Range: |
$2.25 - $6.87 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hsu Larry |
President and CEO |
• • – |
2012-05-11 |
4 |
D |
$22.00 |
$118,118 |
D/D |
(5,369) |
521,534 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2012-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,100 |
132,788 |
|
- |
|
| Benet Leslie Z |
Director |
– • – |
2012-03-15 |
4 |
D |
$23.72 |
$53,251 |
D/D |
(2,245) |
9,755 |
|
- |
|
| Benet Leslie Z |
Director |
– • – |
2012-03-15 |
4 |
OE |
$7.10 |
$53,250 |
D/D |
7,500 |
12,000 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2012-02-13 |
4 |
D |
$22.99 |
$19,404 |
I/I |
(844) |
135,097 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2012-01-11 |
4 |
OE |
$6.72 |
$672,000 |
D/D |
100,000 |
526,903 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2012-01-11 |
4 |
OE |
$7.10 |
$568,000 |
I/I |
80,000 |
135,941 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2011-11-15 |
4 |
D |
$17.16 |
$9,438 |
I/I |
(550) |
55,941 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2011-10-29 |
4 |
D |
$18.93 |
$33,733 |
I/I |
(1,782) |
56,491 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2011-10-28 |
4 |
A |
$0.00 |
$0 |
I/I |
19,435 |
58,273 |
|
- |
|
| Ben-Maimon Carole |
President, Global Pharm. Div. |
• – – |
2011-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,000 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2011-10-26 |
4 |
D |
$18.52 |
$15,631 |
I/I |
(844) |
38,838 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2011-10-11 |
4 |
D |
$19.76 |
$17,665 |
I/I |
(894) |
39,682 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2011-09-01 |
4 |
S |
$19.04 |
$278,746 |
D/D |
(14,640) |
10,666 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2011-08-16 |
4 |
B |
$19.00 |
$190,000 |
D/D |
10,000 |
426,903 |
2.81 |
- |
|
| Benet Leslie Z |
Director |
– • – |
2011-08-08 |
4 |
B |
$15.71 |
$7,855 |
D/D |
500 |
4,500 |
2.39 |
- |
|
| Benet Leslie Z |
Director |
– • – |
2011-08-05 |
4 |
B |
$17.25 |
$17,250 |
D/D |
1,000 |
4,000 |
2.39 |
- |
|
| Schlossberg Mark A |
SVP and General Counsel |
• – – |
2011-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2011-06-10 |
4 |
S |
$20.80 |
$312,000 |
D/D |
(15,000) |
53,625 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2011-06-10 |
4 |
OE |
$6.55 |
$98,250 |
D/D |
15,000 |
68,625 |
|
- |
|
| Markbreiter Michael |
Director |
– • – |
2011-06-07 |
4 |
S |
$23.20 |
$472,949 |
D/D |
(20,334) |
10,666 |
|
- |
|
| Markbreiter Michael |
Director |
– • – |
2011-06-07 |
4 |
OE |
$6.55 |
$98,250 |
D/D |
15,000 |
31,000 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2011-06-07 |
4 |
S |
$23.39 |
$312,682 |
D/D |
(13,334) |
25,306 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2011-06-07 |
4 |
OE |
$6.55 |
$52,400 |
D/D |
8,000 |
38,640 |
|
- |
|
| Terreri Peter R |
Director |
– • – |
2011-06-07 |
4 |
S |
$23.21 |
$64,988 |
D/D |
(2,800) |
22,767 |
|
- |
|
531 Records found
|
|
Page 14 of 22 |
|
|
0.01 (0.16%) 
